MAPT and early-onset autosomal dominant Alzheimer disease: While p-tau181 is a well-established biomarker in Alzheimer's disease and other neurodegenerative diseases, tau isoforms phosphorylated at alternative sites, such as p-tau217 and p-tau231, are also being investigated as biomarkers of neurodegenerative diseases.